Search research articles
Contact Us
Filters
Showing results (61-70 of 92) with videos related to
Page
of 10
Sort By:
European Journal of Cancer & Clinical Oncology
|
April 1, 1987
Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neck
R Abele, M Clavel, S Monfardini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 3, 2000
Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology
H Kappauf, D Leykauf-Ammon, U Bruntsch, et al.
Die Medizinische Welt
|
August 22, 1975
[Cytostatic therapy of primary lympho- and reticulosarcoma of the stomach]
H E Reis, S Passek, U Bruntsch, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1983
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma
H Høst, R Joss, H Pinedo, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin
|
January 1, 1976
[Recent development in the chemotherapy of metastasizing teratocarcinomas of the testis]
W M Gallmeier, R Osieka, S Seeber, et al.
British Journal of Cancer
|
February 1, 1996
Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group
S Kaplan, A R Hanauske, N Pavlidis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma
P Alberto, M Rozencweig, M Clavel, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1987
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas
R Abele, M Clavel, P Dodion, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1984
Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials Group
V H Bramwell, E E Holdener, P Siegenthaler, et al.
Investigational New Drugs
|
January 1, 1985
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)
E E Holdener, H H Hansen, H Høst, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 92) with videos related to
Sort By:
Page
of 10
European Journal of Cancer & Clinical Oncology
|
April 1, 1987
Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neck
R Abele, M Clavel, S Monfardini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 3, 2000
Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology
H Kappauf, D Leykauf-Ammon, U Bruntsch, et al.
Die Medizinische Welt
|
August 22, 1975
[Cytostatic therapy of primary lympho- and reticulosarcoma of the stomach]
H E Reis, S Passek, U Bruntsch, et al.
European Journal of Cancer & Clinical Oncology
|
February 1, 1983
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma
H Høst, R Joss, H Pinedo, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin
|
January 1, 1976
[Recent development in the chemotherapy of metastasizing teratocarcinomas of the testis]
W M Gallmeier, R Osieka, S Seeber, et al.
British Journal of Cancer
|
February 1, 1996
Single agent activity of rhizoxin in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group
S Kaplan, A R Hanauske, N Pavlidis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma
P Alberto, M Rozencweig, M Clavel, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1987
The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas
R Abele, M Clavel, P Dodion, et al.
European Journal of Cancer & Clinical Oncology
|
June 1, 1984
Phase II study of amsacrine in refractory lymphomas. A report of the EORTC Early Clinical Trials Group
V H Bramwell, E E Holdener, P Siegenthaler, et al.
Investigational New Drugs
|
January 1, 1985
Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC)
E E Holdener, H H Hansen, H Høst, et al.
Page
of 10